Too Costly to Throw Away
Read the transcript of “Too Costly to Throw Away”
Film transcript: Too Costly to Throw Away
A nucleotide is costly for a cell to build. Nucleotides are the letters of DNA and RNA, and the carriers of energy, ATP and GTP. They form the cores of signaling molecules like cyclic A M P. They also form the backbones of cofactors such as NAD +, FAD, and coenzyme A. Building their rings from scratch costs a small fortune in ATP. So the cell recycles much of what it has. There are two routes to purine nucleotide, and the difference is mostly about cost. De novo synthesis builds the purine ring atom by atom, directly onto an activated ribose called P R P P. It runs about ten enzymatic steps and spends roughly six ATP to make the first finished purine nucleotide, I M P. Both A M P and G M P branch from I M P.
Salvage takes a free base that already exists, such as hypoxanthine, guanine, or adenine, and reattaches it to P R P P in a single step. The enzyme H G P R T salvages hypoxanthine and guanine. A P R T salvages adenine. Recycling is so much cheaper that many cells recover a large share of their free purines. Salvage is a major source in many tissues. Now imagine the recycling is gone. In Lesch-Nyhan syndrome, an X-linked defect, H G P R T is missing. Free bases that should have been reclaimed are dumped into the catabolic pathway and turned into uric acid. The P R P P that salvage would have used piles up and pushes de novo synthesis even higher. That makes still more purines to degrade.
The result is severe hyperuricemia alongside profound neurological disease. When a purine is finally retired, it is taken apart down a short tail. A M P and adenosine funnel through inosine to hypoxanthine. Then the enzyme xanthine oxidase oxidizes hypoxanthine to xanthine, and xanthine to uric acid. Guanine joins the route one step later, at xanthine. Most mammals carry uricase, which converts uric acid into highly soluble allantoin. Humans and the other apes lost a working uricase during evolution. For us, uric acid is the end product, and it is only sparingly soluble. That missing enzyme makes us prone to gout, along with how well we excrete urate.
Once serum urate climbs past roughly 6.8 milligrams per deciliter, it can crystallize as monosodium urate. A flare is the inflammation those needle-sharp crystals trigger. One fix is to make less of it. Allopurinol, a hypoxanthine look-alike, inhibits xanthine oxidase, so urate production falls and the crystals slowly dissolve. Gertrude Elion and George Hitchings designed it by reasoning about the enzyme.
Nucleotides are costly to build — Lesch-Nyhan lives where recycling breaks, and gout and allopurinol live at the uric-acid end.
Continue in the lesson: Nucleotide Metabolism: Build It, Recycle It, or Pay in Uric Acid →
2:58 · Free, with captions and a transcript. The lesson has the full text, the questions and the sources.
How this film was made. Narration: written from this lesson's text and read by an AI narrator voice (Kokoro, af_heart). Animation: AI-generated in code (Manim) by Claude, a schematic with no drawn molecular structures. Captions come from the narration script. See something wrong? Report it.